An EGLN Inhibitor Protects Normal Tissues and Enables High-dose Radiation Therapy in a Mouse Model of Unresectable Pancreatic Cancer
PHILADELPHIA: – Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and...